A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.

Fact Sheet API

Bill Number

SJRES 22

Introduced

Oct 22, 2007

Latest Action

Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S13201-13202)

Sponsor

Cosponsors

Topics

Administrative procedure Blood Cancer Congress Congressional veto Department of Health and Human Services Government Operations and Politics Health Law Medicare Social Welfare

Full Text

View Full Bill Text

Votes

Summary

Disapproves a specified rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.

Declares that such rule shall have no force or effect.

Actions

Oct 22, 2007

Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S13201-13202)
Oct 22, 2007

Sponsor introductory remarks on measure. (CR S13200-13201)
Oct 22, 2007

Introduced in Senate

Amendments

Related Bills